Ability Inc., through its subsidiaries, provides interception, geolocation, and cyber intelligence products and solutions for security and intelligence agencies, military forces, law enforcement agencies, and homeland security agencies worldwide. It specializes in off-air interception of voice, SMS, and data communication from cellular and satellite communication networks; and deciphering solutions for cellular and satellite communications. The company offers strategic and tactical cellular interception systems for intercepting mobile phone traffic and tracking mobile phone users; and satellite link interception systems, as well as international mobile subscriber identity catchers, advanced CDMA interception systems, in-between interception systems, and ultimate interceptions. It also provides geolocation systems to geographically target mobile phones; cyber solutions that enable the user to extract and view information from mobile phones. Ability Inc. was founded in 1994 and is headquartered in Tel Aviv, Israel.
Company Website : http://www.interceptors.com
Address : Yad Harutzim 14, Tel Aviv, Israel, 6770007
Employees : 17
Fiscal Year End : December
Currency: USD
Country : USA
Beta : 0.30
Short Ratio : 0.16
Shorted Shares : 104,455
200 Day Moving Average : 0.45
Shorted Shares Previous Month : 65,213
50 Day Moving Average : 0.32
Short Percentage : 1.00%
| Symbol | Name | Price(Change) | Market Cap | Price / Earning Ratio | EV/EBITDA |
|---|---|---|---|---|---|
| LGCY | Legacy Reserves Inc |
N/A |
USD61,525,874.67B | 1.10 | 5.30 |
| FTD | FTD Companies, Inc |
N/A |
USD28,725,913.80B | N/A | N/A |
| KEYW | The KeyW Holding Corporation |
N/A |
USD24,651,104.38B | 166.80 | 24.48 |
| SNHY | Helios Technologies, Inc |
N/A |
USD17,848,852.22B | 1,000,000.00 | N/A |
| QTNA | Quantenna Communications, Inc |
N/A |
USD8,997,243.52B | 175.07 | 79.98 |
| INSY | INSYS Therapeutics, Inc |
N/A |
USD4,995,459.82B | 115.90 | N/A |
| CHKE | Apex Global Brands Inc |
N/A |
USD384,202.91B | 17.30 | N/A |
| AMCN | AirNet Technology Inc |
N/A |
USD308,457.30B | 1.00 | N/A |
| PDVW | pdvWireless, Inc |
N/A |
USD95,944.74B | N/A | N/A |
| AIPT | Predictive Oncology Inc |
N/A |
USD38,513.36B | N/A | N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|
N/A
| Market Performance vs. Industry/Classification (Other) |
Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Trailing 12 Months | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Trailing 5 Years | |||||||
| Capital Gain | 2,237.99% | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 2,237.99% | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 4,295.98% | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 4,295.98% | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 8,223.90% | N/A | N/A | N/A | N/A | ||
| Risk Adjusted Return | 52.24% | N/A | N/A | N/A | N/A | ||
| Market Capitalization | 2.89M | N/A | N/A | N/A | N/A | ||
| Letter Grade | Percentage | Letter Grade | Percentage | Letter Grade | Percentage |
| A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
| B+ | 87%-89% | B | 83%-86% | B- | 80%-82% |
| C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
| D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
| F | 0%-59% |
| Ratio vs. Industry/Classification (Other) |
Ratio vs. Market |
||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| Market Value | |||||||
| Price / Earning Ratio | N/A | N/A | N/A | N/A | N/A | ||
| Price/Book Ratio | 0.59 | N/A | N/A | N/A | N/A | ||
| Price / Cash Flow Ratio | -0.57 | N/A | N/A | N/A | N/A | ||
| EV/EBITDA | 0.80 | N/A | N/A | N/A | N/A | ||
| Management Effectiveness | |||||||
| Return on Equity | -492.22% | N/A | N/A | N/A | N/A | ||
| Return on Invested Capital | -124.92% | N/A | N/A | N/A | N/A | ||
| Return on Assets | -28.01% | N/A | N/A | N/A | N/A | ||
| Debt to Equity Ratio | N/A | N/A | N/A | N/A | N/A | ||
| Technical Ratios | |||||||
| Short Ratio | 0.16 | N/A | N/A | N/A | N/A | ||
| Short Percent | 2.02% | N/A | N/A | N/A | N/A | ||
| Beta | 0.30 | N/A | N/A | N/A | N/A | ||
| Letter Grade | Percentage | Letter Grade | Percentage | Letter Grade | Percentage |
| A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
| B+ | 97%-89% | B | 83%-86% | B- | 80%-82% |
| C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
| D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
| F | 0%-59% |
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
No discussions yet
| User Name | Target Rating | Target Horizon (Months) | Target Price | User Analysis | Date | Comment |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total free cash flow in the most recent four quarters.
The company had negative total cash flow in the most recent four quarters.
Do not have an account? Register here
